Bills mount after testicular cancer's return forces UA junior to drop out, move back home

University of Arizona economics junior Nick Palomares, 21, in his bedroom at his parents' house on Tucson's east side. Palomares was diagnosed with testicular cancer last year and was forced to withdraw from class this semester to move back home when the cancer spread.

Bills mount after testicular cancer's return forces UA junior to drop out, move back home

University of Arizona economics junior Nick Palomares keeps a positive attitude while working with phlebotomist Nicy Perez, who is drawing his blood for analysis before an appointment with his oncologist.

Bills mount after testicular cancer's return forces UA junior to drop out, move back home

When 21-year-old University of Arizona student Nick Palomares found out his testicular cancer had come back with a vengeance, he dropped out to focus on healing from "the disease of young men."

Tucson tech: NuvOx drug that aids radiation treatments set for clinical trials

Dr. Evan Unger and his four-year-old Tucson company, NuvOx Pharma, are planning clinical trials of an injectable drug to make tumors more susceptible to radiation treatment.

Tucson tech: NuvOx drug that aids radiation treatments set for clinical trials

Nearly two decades ago, University of Arizona radiologist Dr. Evan Unger recognized that an ultrasound imaging contrast agent he pioneered held promise as a way to deliver drugs or therapies to specific areas.